Inovio Pharmaceuticals
INO
1,28 €
Share price
0.68%
Change (1 day)
-87.29%
Change (1 year)
Categories
Revenue for Inovio Pharmaceuticals (INO)
Revenue in 2025 (TTM): €0.26 Million
According to Inovio Pharmaceuticals's latest financial reports the company's current revenue (TTM 
) is €0.24 Million. In 2024 the company made a revenue of €0.2 Million a decrease over the revenue in the year 2023 that were of €0.75 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Inovio Pharmaceuticals from 1999 to 2025
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2025 (TTM) | €0.26 M | 27.44% |
| 2024 | €0.2 M | -72.2% |
| 2023 | €0.75 M | -92.13% |
| 2022 | €9.56 M | 510.49% |
| 2021 | €1.56 M | -73.99% |
| 2020 | €6.02 M | 64.15% |
| 2019 | €3.67 M | -86.22% |
| 2018 | €26.64 M | -24.28% |
| 2017 | €35.18 M | 4.65% |
| 2016 | €33.62 M | -9.38% |
| 2015 | €37.1 M | 331.58% |
| 2014 | €8.59 M | -11.83% |
| 2013 | €9.75 M | 213.2% |
| 2012 | €3.11 M | -58.72% |
| 2011 | €7.54 M | 63.27% |
| 2010 | €4.61 M | -27.43% |
| 2009 | €6.36 M | 324.25% |
| 2008 | €1.5 M | -54.43% |
| 2007 | €3.29 M | 25.27% |
| 2006 | €2.62 M | -43.05% |
| 2005 | €4.61 M | 436.43% |
| 2004 | €0.86 M | 1245.12% |
| 2003 | €0.06 M | -64.72% |
| 2002 | €0.18 M | |
| 2000 | €5.9 M | -32.44% |
| 1999 | €8.74 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | €53.88 B | 22,063,912.94% | 🇺🇸 USA |
 Johnson & Johnson JNJ | €77.06 B | 31,554,585.82% | 🇺🇸 USA |
 Arrowhead Pharmaceuticals
ARWR | €0.47 B | 192,485.99% | 🇺🇸 USA |
 Novartis NVS | €45.91 B | 18,799,683.82% | 🇨🇭 Switzerland |
 Merck MRK | €55.14 B | 22,579,280.36% | 🇺🇸 USA |
 GlaxoSmithKline GSK | €35.01 B | 14,336,433.75% | 🇬🇧 UK |
 Gilead Sciences GILD | €24.78 B | 10,149,706.25% | 🇺🇸 USA |
 Cleveland BioLabs
CBLI | €0.54 M | 123.19% | 🇺🇸 USA |